Valvular & structural heart disease

5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results

JACC Cardiovasc IntervPublished Prospective multicentre study

Authors' conclusion

MViV, MViR, and ViMAC procedures were associated with sustained improvement of heart failure symptoms and quality of life among survivors at 5 years. Transcatheter heart valve function remained stable in all 3 groups. Patients treated with MViV had excellent survival at 5 years, whereas survival was lower in the MViR and ViMAC groups, consistent with underlying disease severity. Patients with more residual mitral regurgitation had higher mortality.

Study context

Population
Patients at high surgical risk with failed surgical bioprostheses or annuloplasty rings, or severe mitral annular calcification
Participants
91 patients
Exposure
Mitral valve-in-valve (MViV) vs MViR vs valve-in-mitral annular calcification (ViMAC) with balloon-expandable aortic transcatheter heart valves
  • MViVn = 30
  • MViRn = 30
  • ViMACn = 31
Outcome
All-cause mortality, NYHA class I or II, mean mitral gradient
Follow-up
5 years
Methodological details13 US sites, independent echocardiography core laboratories
  • 13 US sites
  • Independent echocardiography core laboratories

Main finding

As reported in the abstract

All-cause mortality

OutcomeMViVMViRViMAC
NYHA class I or II94.7%— not stated in the abstract— not stated in the abstract
Mean mitral gradient6.6 ± 2.5 mm Hg5.8 ± 0.1 mm Hg6.7 ± 2.5 mm Hg
NYHA class I or II (survivors)— not stated in the abstract50%55.6%

— not stated in the abstract

Observational data: associations, not effects.

Further findings

Significant improvements in KCCQ scores when all 3 arms were pooled

Original publication

5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results. JACC Cardiovasc Interv. Published 25 September 2023. doi:10.1016/j.jcin.2023.06.041

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.